Takeover

Acquirers

Crown Laboratories, Inc.

Targets
1
Filings
3
Median premium
—
First filing
Dec 12, 2024
Latest filing
Feb 6, 2025

Targets

CompanyScore before dealScore nowFilingsLatest
Revance Therapeutics, Inc.3 / 7—3Feb 6, 2025

Deal filings

FiledCompanyFormPricePremium
Feb 6, 2025Revance Therapeutics, Inc.8-K——
Jan 21, 2025Revance Therapeutics, Inc.8-K——
Dec 12, 2024Revance Therapeutics, Inc.SC TO-T——